Paraoxonase 1 and atherosclerosis-related diseases

被引：61

作者：

Kotur-Stevuljevic, Jelena ^{[1
]}

Vekic, Jelena ^{[1
]}

Stefanovic, Aleksandra ^{[1
]}

Zeljkovic, Aleksandra ^{[1
]}

Ninic, Ana ^{[1
]}

Ivanisevic, Jasmina ^{[1
]}

Miljkovic, Milica ^{[1
]}

Sopic, Miron ^{[1
]}

Munjas, Jelena ^{[1
]}

Mihajlovic, Marija ^{[1
]}

Spasic, Slavica ^{[1
]}

Jelic-Ivanovic, Zorana ^{[1
]}

Spasojevic-Kalimanovska, Vesna ^{[1
]}

机构：

[1] Univ Belgrade, Fac Pharm, Dept Med Biochem, POB 146, Belgrade 11000, Serbia

来源：

BIOFACTORS | 2020年 / 46卷 / 02期

关键词：

atherosclerosis; cancer; cardiovascular disease; diabetes; HDL dysfunction; paraoxonase; 1; renal disease; stroke; HIGH-DENSITY-LIPOPROTEIN; CORONARY-ARTERY-DISEASE; APOLIPOPROTEIN-A-I; OBSTRUCTIVE PULMONARY-DISEASE; HDL PARTICLE-SIZE; OXIDATIVE STRESS; DIABETES-MELLITUS; PON1; ACTIVITY; HEART-DISEASE; CARDIOVASCULAR-DISEASE;

D O I：

10.1002/biof.1549

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

A direct and an indirect relationship between paraoxonase 1 (PON1) and atherosclerosis exists. Given PON1's physical location within high-density lipoprotein (HDL) particles and its recognized enzyme activity, it is certainly reasonable to suggest that PON1 facilitates the antiatherogenic nature of HDL particles. PON1 also plays a role in regulating reverse cholesterol transport, antioxidative, anti-inflammatory, antiapoptotic, vasodilative, and antithrombotic activities and several endothelial cell functions. HDL dysfunctionality is a more recent issue and seems to be centered on pathological conditions affecting HDL structure and size profiles. This review is focused on the role of PON1 status in different atherosclerosis-related diseases that we have studied over the last twenty years (coronary heart disease, acute ischemic stroke, diabetes mellitus type 2, end-stage renal disease, chronic obstructive pulmonary disease, and sarcoidosis) with the aim to determine the true value of PON1 as a biomarker. The role of PON1 in cancer is also covered, as risk factors and mechanisms underlying both atherosclerosis and cancer share common features.

引用

页码：193 / 205

页数：13

共 139 条

[91] Transcriptional regulation of human Paraoxonase 1 by nuclear receptors [J].

Ponce-Ruiz, N. ;

Murillo-Gonzalez, F. E. ;

Rojas-Garcia, A. E. ;

Mackness, Mike ;

Bernal-Hernandez, Y. Y. ;

Barron-Vivanco, B. S. ;

Gonzalez-Arias, C. A. ;

Medina-Diaz, I. M. .

CHEMICO-BIOLOGICAL INTERACTIONS, 2017, 268 :77-84

[92] The human serum paraoxonase arylesterase gene (PON1) is one member of a multigene family [J].

PrimoParmo, SL ;

Sorenson, RC ;

Teiber, J ;

LaDu, BN .

GENOMICS, 1996, 33 (03) :498-507

[93] Light, but not heavy alcohol drinking, stimulates paraoxonase by upregulating liver mRNA in rats and humans [J].

Rao, MN ;

Marmillot, P ;

Gong, M ;

Palmer, DA ;

Seeff, LB ;

Strader, DB ;

Lakshman, MR .

METABOLISM-CLINICAL AND EXPERIMENTAL, 2003, 52 (10) :1287-1294

[94] Human paraoxonase-3 is an HDL-associated enzyme with biological activity similar to paraoxonase-1 protein but is not regulated by oxidized lipids [J].

Reddy, ST ;

Wadleigh, DJ ;

Grijalva, V ;

Ng, C ;

Hama, S ;

Gangopadhyay, A ;

Shih, DM ;

Lusis, AJ ;

Navab, M ;

Fogelman, AM .

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2001, 21 (04) :542-547

[95] HDL cholesterol and stroke risk: The Multi-Ethnic Study of Atherosclerosis [J].

Reina, Samantha A. ;

Llabre, Maria M. ;

Allison, Matthew A. ;

Wilkins, John T. ;

Mendez, Armando J. ;

Arnan, Martinson K. ;

Schneiderman, Neil ;

Sacco, Ralph L. ;

Carnethon, Mercedes ;

Delaney, J. A. Chris .

ATHEROSCLEROSIS, 2015, 243 (01) :314-319

[96] Determination of paraoxonase (PON1) status requires more than genotyping [J].

Richter, RJ ;

Furlong, CE .

PHARMACOGENETICS, 1999, 9 (06) :745-753

[97] Combined Dyslipidemia: Should the Focus be LDL Cholesterol or Atherogenic Dyslipidemia? [J].

Rizzo, Manfredi ;

Barylski, Marcin ;

Rizvi, Ali A. ;

Montalto, Giuseppe ;

Mikhailidis, Dimitri P. ;

Banach, Maciej .

CURRENT PHARMACEUTICAL DESIGN, 2013, 19 (21) :3858-3868

[98] New Lipid Modulating Drugs: The Role of Microsomal Transport Protein Inhibitors [J].

Rizzo, Manfredi ;

Wierzbicki, Anthony S. .

CURRENT PHARMACEUTICAL DESIGN, 2011, 17 (09) :943-949

[99]

Rizzo M, 2009, CLIN LAB, V55, P421

[100] Tissue distribution and expression of paraoxonases and chemokines in mouse: the ubiquitous and joint localisation suggest a systemic and coordinated role [J].

Rodriguez-Sanabria, Fernando ;

Rull, Anna ;

Beltran-Debon, Raul ;

Aragones, Gerard ;

Camps, Jordi ;

Mackness, Bharti ;

Mackness, Michael ;

Joven, Jorge .

JOURNAL OF MOLECULAR HISTOLOGY, 2010, 41 (06) :379-386

← 5 6 7 8 9 10 11 12 13 14 →